Indications |
Parenteral Falciparum malaria Adult: 2.4 mg/kg via IM or IV admin. Repeat 12 hr and 24 hr later, then once daily thereafter. Child: 2.4 mg/kg via IM or IV admin. Repeat 12 hr and 24 hr later, then once daily thereafter. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
Hepatic or renal insufficiency. Pregnancy and lactation. |
Adverse Reactions |
Transient and reversible reticulocytopaenia, drug fever, rash, bradycardia, transient 1st-degree heart block and reversible elevation of serum transaminases. |
Drug Interactions |
Antimalarial potentiating action seen with mefloquine, primaquine and tetracycline. Additive effect with chloroquine. Antagonistic effect with pyrimethamine and sulphonamides. See Below for More artesunate Drug Interactions |
Mechanism of Actions |
Artesunate is a potent and rapidly-acting blood schizontocide derived from the leaves of the chinese herb, Armesia annua. The exact mode of action is not clear but clinical studies have confirmed the effectiveness of artesunate in P. vivax and falciparum malaria. Excretion: Elimination half-life: about 45 min after IV admin. |
ATC Classification |
P01BE03 - artesunate ; Belongs to the class of artemisinin and derivative antimalarials. |
Available As |
|
Artesunate
Post Review about Artesunate Click here to cancel reply.
Artesunate Containing Brands
Artesunate is used in following diseases
Drug - Drug Interactions of Artesunate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.